Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Lumosa Therapeutics Licenses Long Acting Injectable Analgesic to Skyline Vet Pharma, Inc. for Use in Companion Animals 2018-01-16 18:22
WuXi Biologics Appoints Dr. Chiang Syin, a Former FDA Officer as Chief Quality Officer 2018-01-15 08:10
Australia and Asia Pacific offer international biotech industry a wealth of clinical trial and costs benefits 2018-01-10 09:00
NeuClone Discloses Details of its Fifth Product: A Biosimilar Candidate for Prolia/XGEVA (Denosumab) 2018-01-09 00:00
Novotech wins 2017 Asia Pacific Biotech CRO award 2018-01-08 22:00
China Biologic Announces Corporate Update 2018-01-08 21:00
China Biologic to Attend the 36th Annual J.P. Morgan Healthcare Conference 2018-01-08 21:00
Glucagon Receptor Structure Offers New Opportunities for Type 2 Diabetes Drug Discovery 2018-01-04 10:23
VolitionRx Limited Releases Letter to Shareholders Including Status Update on Key Clinical Milestone 2018-01-03 21:30
Seegene develops world's first multiplex MDx assays with its AI system 2018-01-03 21:00
Foresee Pharmaceuticals and Megapharm Announce License and Distribution Agreement 2018-01-03 20:02
China Biologic Announces Completion of Acquisition of TianXinFu from PWM 2018-01-03 19:00
Lunit Leads the Expansion of AI in the Healthcare Industry 2017-12-30 23:00
Hebron Technology Co., Ltd. Reports Financial Results for the First Half of 2017 2017-12-30 05:15
CStone's anti-CTLA-4 antibody CS1002 filed for clinical trial approval in Australia 2017-12-29 21:00
Sinovac Schedules 2017 Annual Meeting of Shareholders 2017-12-29 19:00
Medical Solution Company Specializing in Stroke Rehabilitation "NEOFECT" 2017-12-28 22:00
CStone files CS1003, an anti-PD-1 antibody, for clinical trial approval in Australia 2017-12-28 10:45
6 European doctors came to West China Hospital, Sichuan University to learn world's first single-direction VATS lobectomy technique 2017-12-27 22:00
CStone files MEK inhibitor CS3006 for clinical trial approval in Australia 2017-12-27 15:41
1 319 320 321 322 323 800